Dr. Robert J. Hartzman

Dr. Robert J. Hartzman, Captain MC USN (Ret), serves as Department Head, Code 05, at the Naval Medical Research Center, where he leads the acquisition and oversight of critical biomedical research technologies essential to force health protection. In this role, he directs the procurement of advanced diagnostic, laboratory, and field-deployable medical systems that support the Navy and Marine Corps in austere and expeditionary environments. His portfolio encompasses high-stakes research and development contracts for innovative medical devices, in-vitro diagnostics, and analytical instrumentation, ensuring that operational medical capabilities remain at the forefront of scientific advancement. Dr. Hartzman maintains a primary working relationship with REES SCIENTIFIC CORPORATION, a trusted vendor specializing in laboratory and field-ready medical equipment. His contracting patterns reflect a preference for established industry partners with proven expertise in biomedical innovation, particularly those capable of delivering ruggedized, FDA-cleared, and military-specification-compliant technologies. He fosters long-term vendor partnerships grounded in technical reliability, rapid prototyping capability, and seamless integration with naval medical workflows. Dr. Hartzman’s procurement strategy does not utilize socioeconomic set-asides, with 100% of his acquisitions conducted under full and open competition. This reflects a mission-driven emphasis on technical merit, performance reliability, and speed of delivery over socioeconomic preferences, prioritizing mission-critical outcomes above compliance-based award structures. His primary NAICS focus areas include Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers; In-Vitro Diagnostic Substance Manufacturing; and Analytical Laboratory Instrument Manufacturing. He routinely procures precision diagnostic platforms, pathogen detection systems, clinical analyzers, and specialized gas delivery systems for laboratory use, demonstrating deep expertise in translational medical technology procurement aligned with force health protection priorities.